Brief: Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation
02/04/2024 21:42
April 2 (Reuters) - Medirom Healthcare Technologies Inc
MRM.O :
* MEDIROM HEALTHCARE TECHNOLOGIES INC - ENTERED INTO A MOU
FOR
PURPOSE OF ACQUIRING ALL SHARES OF STOCK OF JAPAN GENE MEDICINE
CORPORATION
* MEDIROM HEALTHCARE TECHNOLOGIES INC - PROPOSED DEAL FOR
TOTAL
PRICE OF 2.4 BILLION YEN
Source text for Eikon: ID:n0001558370-24-004608
Further company coverage: MRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MEDIROM Healthcare Technologies
See all newsMedirom more than triples on double rollout plan of human authentication devices
Brief: Medirom Decides To Double Installation Of Authentication Device “Orb” To 200 Stores
Brief: Medirom Healthcare Technologies Inc Files For Mixed Shelf Of Up To $50 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Centrus Energy, Tempus AI, Hagerty
Medirom jumps as co partners with ChatGPT creator Sam Altman's World